CA-I2C
i2c Inc. , a leading provider of digital payment and banking technology, today announced its partnership with BEYON Money, the mobile super app launched by Batelco Financial Services , which is the fintech arm of Bahrain’s leading digital solutions and telecommunications provider.
Backed by a recently-secured, first-of-its-kind open banking license from the Central Bank of Bahrain, the BEYON Money super app will host a digital wallet that enables retail, bill, and peer-to-peer payments for its users, connects to bank accounts through open banking, delivers financial insights and provides digital remittances. BEYON Money will develop card issuing and processing functionalities through i2c’s agile banking and payments platform which will also integrate additional partners and services.
Through i2c’s Fintech Fast Track certification, BEYON Money will tap into Visa’s network infrastructure to launch a digital-first debit program to the market with a physical card option available upon request. Additionally, i2c has integrated with local switch, Benefit , connecting consumers to billers across Bahrain, allowing them to pay utilities, rent, mobile, and more via their smartphone. The app is backed by the Central Bank of Bahrain.
“We are proud to partner with BEYON Money and its visionary team as they work to reimagine everyday financial life for their country,” said Aurangzaib Khan, General Manager, MEA Region of i2c Inc. “Our building block technology was designed to help visionaries like Batelco Financial Services to create new possibilities in banking and payments, and their BEYON Money super app is a perfect embodiment of that philosophy.”
According to the World Bank’s Global Findex report, nearly one in five individuals in Bahrain are unbanked, while the nation enjoys a 131% mobile penetration rate. With this super app, Batelco is looking to leverage its leadership position in mobile to accelerate financial inclusion across the nation, with plans to expand to more countries in the near future.
About Batelco Financial Services
Batelco Financial Services Company is located at Batelco’s headquarters in Hamala and comprises a team of national and international expertise in fintech. The newly established company will offer a range of solutions and services for consumers and SMEs, to provide an integrated and seamless banking experience under one platform.
About i2c Inc.
i2c is a global provider of highly-configurable payment and banking solutions. Using i2c's proprietary "building block" technology, clients can easily create and manage a comprehensive set of solutions for credit, debit, prepaid, lending and more, quickly and cost-effectively. i2c delivers unparalleled flexibility, agility, security and reliability from a single global SaaS platform. Founded in 2001, and headquartered in Silicon Valley, i2c's next-generation technology supports millions of users in more than 200 countries/ territories and across all time zones. For more information, visit www.i2cinc.com and follow us at @i2cinc .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005067/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Zetagen Therapeutics to Present Promising Preclinical Data at SABCS: Zeta-BC-007 Demonstrates Superior Tumoricidal Activity and Survival Benefit in Breast Cancer Model4.11.2025 16:48:00 CET | Press release
Survival Advantage: Mice treated with Zeta-BC-007 survived beyond 60 days, unlike those receiving Tamoxifen (TAM) or Abemaciclib (ABE)Tumor Reduction: Zeta-BC-007 combinations reduced tumor volume by up to 66%, compared to 34% (TAM) and 15% (ABE)Synergistic Cytotoxicity: NaN and ABE together decreased cell proliferation by 60% in vitro, suggesting synergistic effectsNo Tumor Activity: Histology revealed no ki67 staining and increased necrosis in Zeta-BC-007-treated tumorsImmune Activation: Treated mice showed elevated macrophage infiltration and increased circulating monocytes Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company pioneering first-of-its-kind targeted therapies for both primary and metastatic breast cancer, announced today that its abstract titled “Increased Survival in Nude Mice Inoculated with MCF7 Breast Cancer (BC) in the Mammary Fat-Pad Achieved via a Single Injection of a Lipid-like Hydrogel Emulsion Containing a New Molecular Entity (NME
A New Era Begins: Visionaries Unite to Shape the Next 50 Years of Tourism at TOURISE4.11.2025 16:35:00 CET | Press release
More than 120 global leaders will convene in Riyadh for the inaugural TOURISE Summit this November, bringing together the largest cross-sector gathering covering all industries that benefit from the trillion dollar tourism sector. From sports, entertainment, media, transport and aviation; representatives from government, business and non-profits will join Expedia, Google, Amadeus, Accor, Nikki Beach, Red Sea Global, Certares and the Public Investment Fund (PIF). From headline panels and visionary keynotes to fireside chats and immersive sessions, TOURISE will spotlight the forces transforming global tourism, and the ideas shaping what comes next for the future of tourism. Get ready to witness history in the making. Over three electrifying days, across two dynamic stages, more than 120 of the world’s most influential visionaries, change-makers, and industry pioneers will converge at the inaugural TOURISE Summit – the boldest global platform designed to unite governments, businesses, inv
Digital Access Reaches Four in Five People Worldwide, DCO’s DEN 2025 Finds4.11.2025 16:35:00 CET | Press release
The Digital Cooperation Organization (DCO), the international organization dedicated to advancing inclusive and sustainable digital economies, today launched the Digital Economy Navigator (DEN) 2025 at the Second World Summit for Social Development (WSSD2) in Doha. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251104849013/en/ From left to right: H.E. Deemah AlYahya, Secretary General of the Digital Cooperation Organization - H.E. Imaan Sulaiman Ibrahim, Honorable Minister of Women Affairs and Social Development, Federal Republic of Nigeria - Alaa Abdulaal, Chief of Digital Economy Insight at the Digital Cooperation Organization. (Photo: AETOSWire) The second edition of the Navigator provides the most comprehensive analysis to date of global digital-economy maturity. Covering 80 countries representing 94 per cent of global GDP and 85 per cent of the world’s population, the report draws on 145 indicators and a survey of more
GEOLOG Unveils the KickMaster™ Flow-Meter Family for Extreme Well Conditions4.11.2025 16:33:00 CET | Press release
Patented instruments deliver reliable Flow-In/Flow-Out, density, and temperature data in high gas-cut and solids-laden muds for onshore and deepwater operations GEOLOG, the largest independent surface-logging company and a pioneer in applying AI to formation evaluation and automated drilling performance, today announced the immediate availability of KickMaster™, a patented family of flow meters engineered to provide accurate, real-time measurements in the most demanding drilling environments. Developed by GEOLOG’s in-house R&D team, KickMaster™ addresses long-standing challenges in measuring heterogeneous mud flows. The system delivers reliable flow, density, and temperature data during critical drilling events, enabling faster detection, better decision-making, and improved well control. Three engineered models for precise flow managementFlow-Out Meter - For standard and high-volume mud returns. Operates reliably with >40% gas in mud and introduces ~70% lower backpressure than typical
Zetagen Therapeutics to Present Preliminary Results from Phase 2 Clinical Trial Targeting Metastatic Breast Cancer to Bone at the 2025 San Antonio Breast Cancer Symposium4.11.2025 16:04:00 CET | Press release
Complete Response in all treated lesions: Patients completing the study showed CR via the MD Anderson Criteria and RECIST v1.1 with no active tumor detected on MRIFirst-of-its-kind single intratumoral injection for MBC to the spineTreated lesions showed full bone regeneration with reconstitution of trabecular bone, and no skeletal related events; mean lesion defect volume decreased by 87.9% at day 180.Therapeutic spread extended to nearby non-treated lesions, also achieving complete response within the same vertebral body Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company pioneering first-of-its-kind targeted therapies for both primary and metastatic breast cancer, announced today that its abstract titled “Single Intratumoral Drug Injection Yields Complete Response (CR) in Metastatic Breast Cancer (MBC) Bone Lesions”, has been accepted and will be presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) on Wednesday, December 10, 2025. The abstract
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom